4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-008518
Global Head of R&D acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Berger Dietmar Global Head of R&D | 2019-02-06 | Grant or award | +25,000 | 75,000 | D | ||
| Derivatives | |||||||
| Berger Dietmar Global Head of R&D | 2019-02-06 | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | D | ||
Loading xslF345X03/doc4.xml…